1240914-48-0

Basic information

• Product Name: (R)-tert-butyl 4-(trans-2-(4-carbamoylphenyl)cyclopropanecarbonyl)-3-methylpiperazine-1-carboxylate
• Synonyms: (R)-tert-butyl 4-(trans-2-(4-carbamoylphenyl)cyclopropanecarbonyl)-3-methylpiperazine-1-carboxylate
• CAS NO: 1240914-48-0
• Molecular Weight: 387.479
• Mol File: 1240914-48-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (R)-tert-butyl 4-(trans-2-(4-carbamoylphenyl)cyclopropanecarbonyl)-3-methylpiperazine-1-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-tert-butyl 4-(trans-2-(4-carbamoylphenyl)cyclopropanecarbonyl)-3-methylpiperazine-1-carboxylate(1240914-48-0)
• EPA Substance Registry System: (R)-tert-butyl 4-(trans-2-(4-carbamoylphenyl)cyclopropanecarbonyl)-3-methylpiperazine-1-carboxylate(1240914-48-0)

Safety Data

• Hazardous Substances Data: 1240914-48-0(Hazardous Substances Data)

Upstream product

• 1119807-15-6 trans-2-(4-cyanophenyl)cyclopropanecarboxylic acid 
• 516520-65-3 (E)‐tert‐butyl 3‐(4‐cyanophenyl)acrylate 
• 105515-33-1 3-(4-bromophenyl)prop-2-en-1-ol 
• 24424-99-5 di-tert-butyl dicarbonate 
• 75336-86-6 (2R)-methylpiperazine 
• 105-07-7 4-cyanobenzaldehyde 
• 163765-44-4 (R)-tert-butyl 3-methylpiperazine-1-carboxylate 

Downstream Products

• 1240914-57-1 4-(trans-2-((R)-2-methylpiperazine-1-carbonyl)cyclopropyl)benzamide 
• 1240914-03-7 4-{(1S, 2S)-2-[((R)-4-cyclobutyl-2-methylpiperazin-1-yl)carbonyl]-cyclopropyl}-benzamide 
• 1240914-02-6 4-((trans)-2-((R)-4-cyclobutyl-2-methylpiperazine-1-carbonyl)cyclopropyl)benzamide 
• 1332343-96-0 4-((trans)-2-((R)-4-cyclobutyl-2-methylpiperazine-1-carbonyl)cyclopropyl)benzamide 

Relevant articles and documents

Solid Forms Comprising A Cyclopropyl Amide Derivative

This disclosure relates to at least one solid form of 4-{(1S, 2S)-2-[((R)-4-cyclobutyl-2-methylpiperazin-1-yl)carbonyl]-cyclopropyl}-benzamide. This disclosure also relates to at least one pharmaceutical composition comprising at least one solid form described herein, methods of using the solid forms and pharmaceutical compositions comprised thereof, and processes of manufacturing the solid forms.